Healthy Nevada Project’s community-based approach reveals up to 90% of CDC Tier 1 genetic condition risks missed using clinical care guidelines
In a new study published today in the journal Nature Medicine, researchers behind the Healthy Nevada Project® suggest that community-based genetic screening has the potential to efficiently identify individuals who may be at increased risk for three common inherited genetic conditions known to cause several forms of cancer and increased risk for heart disease or stroke.
In 2018, the Healthy Nevada Project® (the largest, community-based population health study combining genetic, clinical, environmental, and social data) started notifying consenting study participants who have certain genetic variants that predispose them to the Centers for Disease Control and Prevention (CDC) Tier 1 genetic conditions. The study focused on identifying carriers of these conditions, which include Hereditary Breast and Ovarian Cancer, Lynch Syndrome, and Familial Hypercholesterolemia, because they are the most common conditions and early detection and treatment could significantly lower morbidity and mortality.
Initial results from almost 27,000 study participants showed that 90% of carriers of the CDC Tier 1 genetic conditions were not previously identified in a clinical setting. The authors conclude that population genetic screening would identify at-risk carriers not identified during routine care.
“Our first goal was to deliver actionable health data back to the participants of the study and understand whether or not broad population screening of CDC Tier 1 genomic conditions was a practical tool to identify at-risk individuals,” explained Joseph Grzymski, Ph.D., the principal investigator of the Healthy Nevada Project®, a research professor at the Desert Research Institute (DRI), chief scientific officer for Renown Health and lead author of the study.
“Now, two years into doing that, it is clear that the clinical guidelines for detecting risk in individuals are too narrow and miss too many at-risk individuals.”
Within the group of 26,906 Healthy Nevada Project® participants that Grzymski’s research team studied, 358 (1.33%) were carriers for CDC Tier 1 conditions. However, only 25% of those individuals met clinical guidelines for genetic screening. Additionally, more than 20% of the carriers already had a diagnosis of disease-relevant to their underlying genetic condition.
“We’re at a point now where it’s possible to do clinical-grade genetic screening at population-scale,” added James Lu, M.D. Ph.D., co-founder and chief scientific officer of Helix and senior co-author of the study. “What this study demonstrates is the potential impact of doing so. By making genetic screening available more broadly, we can help the millions of Americans who are unaware that they are living at increased risk for highly actionable, genetic conditions take action.”
Most notably, the study found that of the 273 participants who were carriers of the CDC Tier 1 genetic conditions and had clinical record information, only 22 individuals showed any previous suspicion of their underlying genetic conditions.
“For the first time, we are providing information at the individual level so study participants can make lifesaving changes to reduce their risk based on their genetics,” said Anthony Slonim, M.D., Dr.PH., FACHE, president and CEO of Renown Health and co-director of the Project® study. “We’re conducting research on the community level to develop leading-edge research on health determinants for entire neighborhoods, states and eventually, the country. Returning these results allows us to understand the prevalence of genetically programmed diseases and illnesses that we have here in Nevada and ensure we are providing the best prevention and care plans. For the individual, the return of results can be lifechanging.”
According to the CDC, early detection and intervention of Tier 1 genetic conditions could have a meaningful potential for clinical actionability and a positive impact on public health.
The Healthy Nevada Project®, which launched in 2016, offers free genetic testing to every Nevadan, aged 18 and older, interested in learning more about their health and genetic profile. With more than 50,000 study participants enrolled in four years, the Healthy Nevada Project® has become the fastest-enrolling genetic study in the world. For more about the Healthy Nevada Project® please visit healthynv.org
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Florida House moves to limit transgender students in sportson April 14, 2021 at 4:14 pm
Florida lawmakers moved closer to requiring transgender athletes to undergo testosterone or genetic testing — as well as submit to having their genitalia examined — to ...
- Testing Shows Animal Killed in Eastern Nebraska Was Wolfon April 14, 2021 at 10:40 am
Nebraska wildlife officials say genetic testing has shown that an animal killed in January by coyote hunters north of Fremont was a gray wolf.
- Under-resourced genetic counselling and testing services proving barrier to access for HCPson April 14, 2021 at 8:03 am
Under-resourced cancer genetic counselling and testing services are proving to be barriers for access for six out of 10 healthcare professionals surveyed while over four in 10 underline concerns about ...
- Grand Rapids genetic testing company’s partnership offers pooled COVID-19 testing for public schoolson April 14, 2021 at 6:30 am
NxGen MDx, which specializes in genetic testing, said even as teachers and guardians become eligible for vaccines, clinical vaccine trials for individuals under 16 are just beginning, and efforts ...
- Global Genetic Testing Market Report 2021-2025: Newborn, NIPT, Predictive, Oncology, DTC, Others - COVID-19 Crowds Out Other Serviceson April 13, 2021 at 1:38 am
3.3.2 Bioinformatics Plays a Role. 3.4 Diagnostic Technology Development 3.4.1 Next Generation Sequencing Fuels a Revolution.
Go deeper with Google Headlines on:
Go deeper with Bing News on:
Community-based genetic screening
- Relay Medical and Fio Partner with LifeLabs, Canadian Healthcare Leader, to Deploy Fionet Platform for COVID-19 Testing Nationwideon April 14, 2021 at 4:33 pm
Relay Medical and Fio Partner with LifeLabs, Canadian Healthcare Leader, to Deploy Fionet Platform for COVID-19 Testing Nationwide GlobeNewswire April 14, 2021 TORONTO, April ...
- Monday COVID-19 Roundup: L.A. County Death Rate Higher for Men Than Women; SCV Cases Total 27,482on April 12, 2021 at 7:32 pm
Testing results are available for more than ... faith-based organizations, and community-based organizations. These mobile sites are critical to our effort to vaccinate hard-hit communities ...
- Luma Health Celebrates One Millionth COVID-19 Vaccination And Scales Up For Millions Moreon April 9, 2021 at 9:43 am
Now, Luma Health's platform is ready to help providers from community-based health centers to large multi-state ... Despite these worries, The Conference Board survey reveals that... at 12:25 Global ...
- LUCIRA COVID-19 Test Kit Identifies Viral Variantson April 9, 2021 at 7:00 am
Unlike other variants, it has two genetic mutation sequences that the Center for Disease ... which can miss active COVID-19 infections. In a Community-based clinical trial, the LUCIRA COVID-19 ...
- LUCIRA COVID-19 Test Kit Identifies Viral Variantson April 9, 2021 at 3:31 am
Tax Planning Personal Finance Save for College Save for Retirement Invest in Retirement Research Mutual Funds Stocks ETFs Bonds Best Investments ...